Sintact Medical Systems, Inc. develops non-resorbable films that separate adjacent organs from attaching to each other after surgery. The Sintact film acts as a polymeric tissue substitute that separates organ and tissue surfaces to significantly reduce the likelihood of tissue attachment and associated post-operative complications.
News Highlights
► 4/7/17 Sintact awarded an NSF Phase 2 SBIR Grant
► 9/25/16 Sintact becomes a VentureWell portfolio company
► 7/25/16 Sintact was selected as a semifinalist in the 43North Competition
► 6/29/16 Sintact completes proof-of-concept animal study for neurological applications
► 4/5/16 US Patent issued for core Sintact technology
News Archive
► 9/25/16 Sintact becomes a VentureWell portfolio company
► 7/25/16 Sintact was selected as a semifinalist in the 43North Competition
► 6/29/16 Sintact completes proof-of-concept animal study for neurological applications
► 4/5/16 US Patent issued for core Sintact technology
News Archive